KR0184719B1 - Pinus koraiensis sieb powder - Google Patents
Pinus koraiensis sieb powder Download PDFInfo
- Publication number
- KR0184719B1 KR0184719B1 KR1019950001352A KR19950001352A KR0184719B1 KR 0184719 B1 KR0184719 B1 KR 0184719B1 KR 1019950001352 A KR1019950001352 A KR 1019950001352A KR 19950001352 A KR19950001352 A KR 19950001352A KR 0184719 B1 KR0184719 B1 KR 0184719B1
- Authority
- KR
- South Korea
- Prior art keywords
- pine
- extract
- powder
- extract powder
- weight
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims abstract description 35
- 240000007263 Pinus koraiensis Species 0.000 title claims abstract description 6
- 235000011615 Pinus koraiensis Nutrition 0.000 title claims abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 49
- 241000018646 Pinus brutia Species 0.000 claims abstract description 34
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 27
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000014103 egg white Nutrition 0.000 claims abstract description 15
- 210000000969 egg white Anatomy 0.000 claims abstract description 15
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 14
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000706 filtrate Substances 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 abstract description 8
- 235000019606 astringent taste Nutrition 0.000 abstract description 6
- 150000001413 amino acids Chemical class 0.000 abstract description 5
- 235000018553 tannin Nutrition 0.000 abstract description 5
- 239000001648 tannin Substances 0.000 abstract description 5
- 229920001864 tannin Polymers 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 235000015872 dietary supplement Nutrition 0.000 abstract description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 abstract description 2
- 235000008578 Pinus strobus Nutrition 0.000 abstract description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 abstract description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 abstract description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 abstract description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 abstract description 2
- 235000005493 rutin Nutrition 0.000 abstract description 2
- 229960004555 rutoside Drugs 0.000 abstract description 2
- 238000001694 spray drying Methods 0.000 abstract description 2
- 240000007320 Pinus strobus Species 0.000 abstract 1
- -1 ethyl agate Chemical compound 0.000 abstract 1
- 238000003306 harvesting Methods 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 4
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 3
- 229940115397 bornyl acetate Drugs 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 2
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241000218641 Pinaceae Species 0.000 description 2
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 229930006722 beta-pinene Natural products 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000018783 Dacrycarpus dacrydioides Nutrition 0.000 description 1
- 235000018782 Dacrydium cupressinum Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000001439 Opuntia Species 0.000 description 1
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000013697 Pinus resinosa Nutrition 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- LFLZOWIFJOBEPN-UHFFFAOYSA-N nitrate, nitrate Chemical compound O[N+]([O-])=O.O[N+]([O-])=O LFLZOWIFJOBEPN-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229940013712 pineapple extract Drugs 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229950001574 riboflavin phosphate Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
본 발명은 해송(Pinus Koraiensis Sieb. et Zucc)잎을 물, 에탄올 또는 그의 혼합용액으로 60-70℃에서 추출하여 추출액을 얻고, 여액을 에칠에테르 및 에칠애게테이트로 연속적으로 추출하여 유기용매층을 모은후 이를 감압농축하여 해송잎 연조엑스를 제조하고, 여기에 5%난백 20-40중량%를 가하여 탄닌을 제거한후, 감압농축후 분무건조하여 해송잎 엑스파우더를 제조하는 것이다.The present invention extracts the leaves of Pinus Koraiensis Sieb. Et Zucc with water, ethanol or a mixture thereof at 60-70 ℃ to obtain an extract, the filtrate is continuously extracted with ethyl ether and ethyl agate to form an organic solvent layer After harvesting, the extract was concentrated under reduced pressure to prepare soft pine extract, and 20% to 40% by weight of 5% egg white was added thereto to remove tannins, and then concentrated under reduced pressure to dry by spray drying to produce pine cone extract.
제조된 해송잎 엑스파우더는 떫은맛이 없이 복용이 편리하고, 루틴 및 각종 아미노산등을 함유하고 있어 순환계질환등 치료시에 건강보조식품으로 사용이 가능하다는 특장점이 있다.The manufactured pine pine extract powder is convenient to take without astringent taste, and contains rutin and various amino acids, so it can be used as a health supplement in the treatment of circulatory diseases.
Description
제1도는 해송잎 엑스파우더중 루틴성분을 실험한 UV Chart이다.1 is a UV chart that tests the routine components of the pine pine extract powder.
제2도는 해송잎 엑스파우더중 각종 아미노산을 실험한 아미노산 분석 Chart이다.2 is an amino acid analysis chart of the experiment of various amino acids in the pine pine extract.
제3도는 해송잎 엑스파우더중 정유성분을 분석한 GC- MS Chart이다.3 is a GC-MS chart of essential oils in the pine leaf extract powder.
본 발명은 해송잎 엑스파우더의 제조방법 및 그의 용도에 관한 것이다.The present invention relates to a method for producing a pine pine extract and its use.
해송(海松, Pinus Koraiensis Sieb. et Zucc)은 홍송이라고도 하며 과송(장백산)이라는 별명도 있으며, 소나무과(Pinaceae)에 속하는 높이 약30m, 좌우둘레 약 1m의 가지가 넓게 편쳐져 있고 수관은 탑모양인 상록교목으로, 중국장백산, 한반도, 일본, 소련등지에서 자라고, 수피는 회홍강색이며 인편모양으로 갈라져 떨어지고 새로갈라진면은 홍갈색이다. 해송잎초는 일찍 떨어지고 일속에 5개 침이 있고 곧은 것도 있고 약간 굽은 것도 있으며 길이 6-12cm로, 횡단면이 삼각형이고 기공선이 있으며, 기공선이 없는면은 겉은 녹색을 띄고 주변에 좁은 톱니모양이 있고 내부에는 유관속하나 지방통로 3개가 있다.Haisong (Pinus Koraiensis Sieb. Et Zucc), also known as Hongsong, also known as Gwasong (Jangbaeksan), is a branch of the pine family (Pinaceae) about 30m high and about 1m wide. It is an evergreen tree growing in Changbai Mountain, Peninsula, Japan, Soviet Union, etc., and bark is gray reddish, split into pieces and reddish brown. The pine needles fall early, with 5 needles in the day, straight and slightly curved, 6-12cm long, with a triangular cross section and a pore line, and green without the pore line and narrow serrated around There are three kinds of local corridors but internal corridors.
해송잎은 맛은 쓰고 성질은 더우며, 민간에서는 유행성감기, 풍습증, 고혈압, 신경쇠약등에 30-60g을 사용한다고 알려져 있다.(장백산 식물도감 및 본초강목 참조)It is known that sea pine leaves have a bitter taste and hot nature, and 30-60g is used in folk medicine for influenza, acupuncture, hypertension, and nervous breakdown (see Changbai Mountain Plant Book and Herb Herb).
최근 해송잎에는 정유성분 및 후라보노이드가 함유되어 있으며, 정유의 성분으로는 α-피넨, β-피넨, 캄펜, 카렌, 테르피놀론, 리모넨, 보르닐아세테이트가 함유되어 있고, 세스퀴텔펜, 디테르펜등의 후라보노이드계 성분이 많이 함유되어 있어 해열, 진통, 항염 및 항경련작용이 있음이 밝혀진바 있다.Recently, the seaweed leaves contain essential oils and flavonoids, and essential oils include α-pinene, β-pinene, camphor, karen, terpinolone, limonene, bornyl acetate, sesquitelphen and diterpene. Flavonoid-based components, such as a lot of it has been found to have antipyretic, analgesic, anti-inflammatory and anti-convulsive action.
지금까지의 해송잎 복용방법은 잘게 분쇄하여 그대로 복용하거나, 잘게 분쇄한후 물에 침지, 여과하여 침출액을 복용하는 방법이 고작이었고 이들은 탄닌의 떫은 맛을 지니고 있어 이를 주제로한 건강식품의 맛과 질은 조악하였다.Until now, the method of taking sea pine leaves was taken by crushing finely, or by dipping them into water and then leaching them by filtration. Jill was coarse.
따라서, 본 발명은 상기와 같은 결점을 해소함은 물론, 기존의 해열, 진통, 함염 및 항경련작용외에 순환계질환치료효과보다도 기대될 수 있는 해송잎의 유효성분을 함유한 복용이 편리한 해송잎 엑스파우더를 제공함을 목적으로 하고 있다.Therefore, the present invention solves the above drawbacks, as well as the existing antipyretic, analgesic, salt-containing and anti-convulsant action in addition to the effective treatment of circulating diseases that can be expected to contain the effective ingredient of the seaweed leaf pine powder extract The purpose is to provide.
상기와 같은 본 발명의 목적을 달성하기 위한 본 발명의 기술구성을 설명하면 다음과 같다.Referring to the technical configuration of the present invention for achieving the above object of the present invention.
해송잎을 추출하여 해송잎엑스를 제조한후, 여기에 유효량의 난백을 첨가시켜 혼합한후, 원심분리하여 침전물을 제거한 엑스를 분무건조하여 해성잎엑스파우더를 제조하는 것이다.After extracting the pine pine leaves to prepare the pine pine extract, the effective amount of egg white is added to the mixture, and centrifuged to remove the precipitate by spray-drying to prepare a marine leaf extract powder.
보다 구체적으로 설명하면, 해송잎을 채취하여 그늘에서 건조시킨후 분쇄한 분말을 물 또는 에탄올, 또는 그의 혼합용액으로 60~70℃에서 추출, 여과하여 여액을 얻고, 이를 감압농축한다음, 열수를 가하여 진탕여과하여 여액을 얻은후, 이 여액을 에칠에테르로 추출하여 유기용매층은 분획하고 남은 수층은 에칠에테르를 제거한후 실온으로 냉각시키고 에칠아세테이트로 추출한후 유기용매층을 분획하고, 이용매층을 모아 감압농축후 건조시켜 해송잎 연조엑스를 제조한다음, 이 해송잎연조엑스에 5%난백 1-50중량%, 바람직하게는 20-40중량%에 해당하는 양을 가하여 60℃에서 30분간 균질화시킨후 고속원심분리하여 탄닌을 제거하고, 감압농축후 분무건조하여 해송잎엑스파우더를 제조한다.To explain more specifically, the pine leaves are collected and dried in the shade, and then the powder is pulverized and extracted with filtrate at 60 to 70 ° C. with water or ethanol or a mixed solution thereof, and the filtrate is concentrated under reduced pressure. After the filtrate was shaken to obtain a filtrate, the filtrate was extracted with ethyl ether, and the organic solvent layer was partitioned. The remaining aqueous layer was removed with ethyl ether, cooled to room temperature, extracted with ethyl acetate, and then the organic solvent layer was fractionated. Collect the dried pineapple extract after drying under reduced pressure, and add 5% egg white 1-50% by weight, preferably 20-40% by weight, to homogenize at 60 ℃ for 30 minutes. After removing the tannin by centrifugation at high speed, concentrated under reduced pressure and spray-dried to prepare a pine leaf extract powder.
본 발명을 수행함에 있어, 에탄올 추출시 추출온도는 60-70℃이고, 2-4시간 2-3회 반복추출하는 것이 추출효과를 극대화할 수 있다.In carrying out the present invention, the extraction temperature during ethanol extraction is 60-70 ℃, repeated extraction 2-4 hours 2-3 times can maximize the extraction effect.
본 발명에서 계란에서 채취된 난백을 가하고 있는바, 연조엑스에 함유된 떫은 맛의 성분인 탄닌성분을 제거하기 위함으로, 그 사용량은 5%난백 기준시 연조엑스에 대하여 1-50중량%, 바람직하게는 20-40중량%에 해당하는 양을 사용하는 것이며, 탄닌의 제거기전은 탄닌과 난백성분과의 분자결합으로 인하여 침전물이 형성되는 것으로, 형성된 침전물은 원심분리에 의하여 용이하게 연조엑스로부터 분리, 제거할 수 있는 것이다.In the present invention is added to the egg white collected from the egg, to remove the tannin component of the astringent taste contained in the softening extract, the amount of use is 1-50% by weight, based on the softening extract based on 5% egg white, preferably Preferably, the amount corresponding to 20-40% by weight is used, and the removal mechanism of tannin is that a precipitate is formed by molecular bonding of tannin and egg white component, and the formed precipitate is easily separated from the soft extract by centrifugation. It can be removed.
본 발명에 따라 제조된 해송잎엑스파우더는 떫은맛이 없어 복용이 편리하고, 식품첨가물로서 손색이 없을뿐만아니라, 후라보노이드계 성분인 루틴등이 함유되어 있어 순환계질환 치료시 보조음용이 가능한 단독 또는 타성분과 함께 건강식품, 건강음료, 탄산음료, 다(茶 )류 및 의약드링크제의 주원료 또는 보조첨가물로서 사용할 수 있는 특장점이 있는 것이다.Hae pine leaf extract powder prepared according to the present invention is convenient to take because it has no astringent taste, and is not inferior as a food additive, and contains a routine such as a flavonoid-based ingredient, which can be used alone or in other ingredients when treating circulatory diseases. In addition, there is a feature that can be used as a main ingredient or supplement of health foods, health drinks, carbonated drinks, tea and pharmaceutical drinks.
이하 본 발명의 실시예 및 실험예등을 기재한다.Hereinafter, examples and experimental examples of the present invention will be described.
[실시예1]Example 1
해송잎을 일정시간 그늘에 건조하여 잘게 부순 홍송 100g을 2리터의 에탄올에 넣고 60℃에서 2시간동안 2회 추출하여 여과한다.The pine needles are dried in a shade for a certain time, and 100 g of finely crushed red pine leaves are put in 2 liters of ethanol, and extracted by filtration twice at 60 ° C. for 2 hours.
다음에 여액을 60℃이하에서 감압농축한다음 여기에 열수 1리터를 가하여 진탕한다음 여과한다.The filtrate is then concentrated under reduced pressure at 60 ° C. or lower, and thereafter, 1 liter of hot water is added thereto, followed by shaking.
그 여액을 실온까지 냉각한다음 에테르 1리터를 가해 혼합교반한다음 유기용 매층이 맑아질때까지 20-30℃에서 1시간씩 3회 반복 추출하여 유기용매층을 분획한다.The filtrate was cooled to room temperature, 1 liter of ether was added, the mixture was stirred, and the organic solvent layer was fractionated by extracting three times at 20-30 DEG C for 1 hour until the organic solvent layer became clear.
남은 수층을 수욕상에서 가온하여 에테르를 완전제거하고 실온에 방치하여 냉각시킨다. 여기에 에칠아세테이트 1리터를 가해 혼합교반한다음 유기용매층이 맑아질때까지 3회 반복 추출하여 유기용매층을 모아서 분획한다.그 용매층을 농축건조하고 여기에 계란으로부터 채취된 5%난백(25g)을 물에 녹인 다음 일정온도에서 해송엑기스에 난백수용을 혼합시킨후 일정시간이 경과된후 난백침전물을 원심분리하여 제거하고 분리된 액은 감압농축한후, 분무건조시켜 해송잎엑스파우더 4.0g을 얻었다.The remaining aqueous layer is warmed in a water bath to completely remove the ether and left to cool to room temperature. Add 1 liter of ethyl acetate, stir and mix, and extract the organic solvent layer three times until the organic solvent layer is clear. The organic solvent layer is concentrated to dryness and 5% egg white (25 g) collected from eggs. After dissolving in water and mixing egg white water with Haesong extract at a certain temperature, after a certain time, egg white sediment is removed by centrifugation. The separated solution is concentrated under reduced pressure, spray-dried and dried. Got.
본 발명의 실시예1에 따라 제조된 해송잎 엑스파우더는 다음과 같은 실험수치를 보였다.The sea pine leaf extract powder prepared according to Example 1 of the present invention showed the following experimental values.
(다음)(next)
1)성상 : 특이취가 나는 갈색의 건조엑스파우더.1) Appearance: Brown dry extract powder with unusual odor.
2)확인시험 : 해송잎엑스파우더 1g을 취하여 물 100ml를 넣어 흔들어 용해시킨후 0.5%젤라틴용액 50ml를 가할때 백색침전이 형성되지 않는다.2) Identification test: Take 1g of pine leaf extract powder, add 100ml of water, shake to dissolve, and add 50ml of 0.5% gelatin solution. No white precipitate is formed.
3)수분 : 10%이하(칼핏셔법)3) Moisture: 10% or less (Kalfitshire method)
4)중금속 : 30ppm이하4) Heavy metal: 30ppm or less
5)비소 : 4ppm이하5) Arsenic: 4ppm or less
6)회분 : 10.0%이하6) Ash: Less than 10.0%
7)산불용성회분 : 1.0%이하7) Acid insoluble ash: 1.0% or less
8)이물시험 : 적합8) Foreign body test: suitable
9)타르색소 : 불검출9) Tar Color: Not detected
10)대장균 : 음성10) Escherichia coli: negative
나아가, 본 실시예1에 따라 제조된 파우더중 함유된 루틴(rutin)성분의 UV Chart를 제1도에 나타내었다.Furthermore, the UV chart of the rutin ingredient contained in the powder prepared according to Example 1 is shown in FIG. 1.
*실험조건 : SHT=2×2 SCAN WIDTH=8* Experimental Condition: SHT = 2 × 2 SCAN WIDTH = 8
λ=267 DRIFT=25λ = 267 DRIFT = 25
MIN AREA=10, 000MIN AREA = 10, 000
*계산 : *Calculation :
따라서, 본 발명의 해송잎 엑스파우더중 순환기계용 약제유효성분인 루틴이 약 0.03%정도 함유되어 있음을 확인할 수 있었다.Therefore, it was confirmed that the routine ingredient, which is the active ingredient of the pharmaceutical agent for the circulatory machine, contained about 0.03% of the pine needle extract powder of the present invention.
한편, 실시예1에서 따라 제조된 해송잎 엑기스파우더 100g중 함유하고 있는 각종 아미노산의 분석결과를 아래 표1에 기지하였고(실험기기 : 히다찌사 아미노산분석기), 분석 Chart를 제2도에 나타내었다.On the other hand, the analysis results of the various amino acids contained in 100g of pine needle extract powder prepared according to Example 1 are based on Table 1 (Experimental Equipment: Hitachi company amino acid analyzer), the analysis chart is shown in FIG.
또한 실시예1에 따라 제조된 해송잎 엑스파우더 100g중에 함유되어 있는 각종 정유성분을 가스크로마토그래프 매스 스펙트로메타(gas-chromatograph mass spectrometer)를 사용하여 확인, 분석하였다.In addition, various essential oil components contained in 100 g of pine needle extract powder prepared according to Example 1 were identified and analyzed using a gas chromatograph mass spectrometer.
1)사용기기 : PYE-204 gas chromatograpy.1) Equipment used: PYE-204 gas chromatograpy.
칼럼 : SE-54 Capillary Columm(23m×0.25mm)Column: SE-54 Capillary Columm (23m × 0.25mm)
온도 program : 50~200℃ (승온)Temperature program: 50 ~ 200 ℃ (raising temperature)
Carrier gas : HeCarrier gas: He
주입량 : 0.2μlInjection volume: 0.2μl
2)사용기기 : VGMM 7070H mass spectrometer2) Equipment: VGMM 7070H mass spectrometer
resolution 600, ionization 방식 (EI ion source)resolution 600, ionization method (EI ion source)
온도200℃Temperature 200 ℃
NG 2035 RecorderNG 2035 Recorder
실험결과를 하기 표2에 기재하였으며, 해송잎 엑스파우더 정유성분으로는 10가지 성분을 분리, 감정할 수 있었으며, 그중에 α-피넨, 캄펜(camphene), β-피넨, 리모넨(Limonene), 보르닐아세테이트(bornyl acetate), α-텔피노렌(α-terpinolene ), δ-3-카렌(caren) 및 미르센(myrcene)등 10직종의 정유성분이 함유되어 있음을 확인, 분리검정하였다. 분석 Chart를 제3도에 나타내었다.The experimental results are shown in Table 2 below. As the essential oil components of sea pine leaf extract powder, 10 components could be separated and evaluated. Among them, α-pinene, camphene, β-pinene, limonene, and bornyl Acetate (bornyl acetate), α-terpinolene (α-terpinolene), δ-3-karen (caren) and mycene (myrcene) containing 10 essential oils were identified and separated. The analysis chart is shown in FIG.
[실시예 2-8]Example 2-8
실시예1과 동일하게 수행하되, 5%난백 무첨가시와 5%난백 10중량%씩 중량하여 해송잎 엑스파우더를 제조한 후, 각 실시예별로 떫은맛에 대한 판넬시험을 수행한 결과를 표3에 기재하였으며, 표3에서 볼 수 있는 바와같이, 난백의 첨가량이 20-40중량%임이 가장 바람직함을 알 수 있다.The same procedure as in Example 1, except that 5% egg white no addition and 5% egg white by weight of 10% by weight to prepare the pine leaf extract powder, the results of performing a panel test for astringent taste for each Example in Table 3 As shown in Table 3, it can be seen that the addition amount of egg white is most preferably 20-40% by weight.
※떫은맛 평가 : ++매우강함※ Slight taste evaluation: ++ very strong
+ 느낄수있음+ Can feel
- 전혀느낄수없음-Can't feel it at all
[실시예9-19]Example 9-19
실시예1과 동일하게 실시하되 난백량은 30중량%로 고정후, 주추출용매와 온도조건을 달리한 경우 다음과 같은 결과를 얻었다.(표4참조)The same procedure as in Example 1 was carried out, but the egg white content was fixed to 30% by weight, and the following results were obtained when the main extraction solvent and the temperature conditions were different (see Table 4).
상기 실시예 1및 2-8에서 볼수 있듯이, 떫은맛을 완전히 제거할 수 있었고, 상기 실시예9-19에서 볼 수 있듯이 추출용매로 에탄올을 사용하여 60-70℃에서 추출함이 유효성분의 활성유지, 엑스파우더량의 수율면에서 가장 바람직함을 알수 있다.As can be seen in Examples 1 and 2-8, the astringent taste was completely removed, and as shown in Examples 9-19, the extract was maintained at 60-70 ° C. using ethanol as the extraction solvent to maintain the active ingredient. It can be seen that the most preferable in terms of yield of the amount of powder.
본 발명에 따라 제조된 해송잎엑스파우더의 1회복용량은 50-2000mg, 바람직하게는 100-500mg이며, 청량음료, 건강보조식품, 기타 식품의 다(茶)류및 소세지에 첨가시에는 상기 파우더 0.1-10w/v%, 바람직하게는 0.1-5w/v% 의 범위내에서 포함시킴이 바람직하다.The recovery capacity of the pine pine extract powder prepared according to the present invention is 50-2000 mg, preferably 100-500 mg, and the powder is added to the tea and sausage of soft drinks, health supplements, and other foods. It is preferable to include in the range of 0.1-10w / v%, preferably 0.1-5w / v%.
본 발명에 따라 제조된 해송잎엑스파우더는 식품 및 의약의 제제학적으로 허용가능한 범위내에서 방부제나 보존제를 첨가할 수 있다.Sea pine leaf extract powder prepared according to the present invention may add a preservative or preservative within the pharmaceutically acceptable range of food and medicine.
이하, 본 발명에 따른 해송잎엑스파우더를 함유한 제제의 처방조성예를 보면 다음과 같다.Hereinafter, the formulation example of the formulation containing the sea pine leaf extract powder according to the present invention is as follows.
[제제예1][Example 1]
해송잎엑스파우더 500.0mgHaesong Leaf Extract Powder 500.0mg
──────────────────────────────
1cap.1cap.
[제제예2][Example 2]
해송잎엑스파우더 500.0mgHaesong Leaf Extract Powder 500.0mg
벌꿀 150.0mgHoney 150.0mg
백당 3000.0mg3000.0mg per bag
안식향산나트륨 50.0mgSodium benzoate 50.0 mg
구연산 100.0mgCitric Acid 100.0mg
정제수 적량Purified water
──────────────────────────────
총(pH 4.0) 120mlTotal (pH 4.0) 120ml
[제제예3][Example 3]
해송잎엑스파우더 500.0mgHaesong Leaf Extract Powder 500.0mg
가시오가피 건조엑스 50.0mgPrickly Pear Dry Extract 50.0mg
아미노 에칠 슬폰산 1000.0mgAminoethylsulfonic acid 1000.0mg
니코틴산 아미드 20.0mgNicotinic Acid Amide 20.0mg
질산치아민 5.0mgNitric acid nitrate 5.0mg
염산 피리독신 5.0mgPyridoxine Hydrochloride 5.0mg
인산 리보플라빈 5.0mgRiboflavin Phosphate 5.0mg
고 과당 5.0g5.0g high fructose
설탕 5.0g5.0 g of sugar
구연산 150.0mgCitric Acid 150.0mg
정제수 적량Purified water
──────────────────────────────────
총 120ml120 ml total
[제제예4][Example 4]
해송잎엑스파우더 500mgHaesong Leaf Extract Powder 500mg
야자유 350mgPalm oil 350mg
콩기름 150mgSoybean Oil 150mg
백납 15mg15 mg of lead
젤라틴 250mgGelatin 250mg
농글리세린 60mgConcentrated glycerin 60 mg
D-솔비톨액 40mgD-sorbitol solution 40mg
파라옥시안식향산메칠 1mgParaoxybenzoic Acid Methyl 1mg
파라옥시안식향산프로필 10.2mg10.2mg of paraoxybenzoate
정제수 150mg150mg purified water
에탄올 0.3mgEthanol 0.3mg
에칠바닐린 적량Echivanillin Correction
산화티탄 1.5mgTitanium oxide 1.5mg
황색5호 적량Yellow No. 5
적색40호 적량Red No. 40
청색1호 적량Blue No. 1
────────────────────────────────────
총(연질캅셀) 1600mgTotal (soft capsule) 1600 mg
다음, 해송잎 엑스파우더의 급성독성시험을 실시하고 그 결과를 기재하였다.Next, the acute toxicity test of the pine leaf extract powder was performed and the results were described.
1.실험재료1. Experimental materials
(1)재료:실시예1에 따라 제조된 해송잎 엑스파우더를 실험시 농도 25%의 수용액으로 제조한다.(0.25g/ml)(1) Material: The pine cone extract powder prepared according to Example 1 was prepared in an aqueous solution having a concentration of 25% during the experiment. (0.25 g / ml)
(2)동물:체중 20-22g의 1CR계 흰쥐(2) Animal: 1CR rat of 20-22 g in weight
2.실험방법2.Experimental Method
20마리의 쥐를 암컷과 수컷 각각 정반씩 나누어 투여하는데, 농도는 0.25g/ml파우더 수용액으로하여 흰쥐에게 적용가능한 최대의 양을 매일 두번씩 흰쥐의 위(胃)에 투약한후 계속 7일간 관찰하였다.Twenty rats are divided into two groups, female and male, each with a concentration of 0.25 g / ml powder and the maximum amount applicable to the rats is administered twice daily to the rat's stomach for 7 days. It was.
실험이 계속된후 쥐의 체중을 측정하여 매일 쥐의 해성잎 엑스파우더에 대한 변화상황을 기록하였다.After the experiment was continued, the weight of the rats was measured, and the change status of the mice's defoliated leaf powder was recorded daily.
3.실험결과3. Experimental results
쥐를 7일간 관찰한 결과, 체중이 평균 매일 0.9 0.2g증가하며 상태가 좋고 활발하며 모색이 광빛이 난다.The rats were observed for 7 days, and the weight gained 0.9 0.2g on average daily.
흰쥐에 대한 해송잎엑스파우더 최대 용량은 25g/Kg이었다.The maximum dose of sea pine leaf extract powder in rats was 25g / Kg.
4.실험소견4. Experimental findings
흰쥐의 해송잎 엑스파우더에 대한 최대 용량이 25g/Kg인데 이 양은 635g/Kg의 해송잎에 상당한다.The maximum capacity of the white pine cypress leaves is 25g / Kg, which is equivalent to 635g / Kg.
따라서, 실험결과 해송잎 엑스파우더는 무독성이라는 것을 알수 있었다.Therefore, the experimental results showed that the pine leaf extract powder was non-toxic.
이상과 같이, 본 발명의 해송잎 엑스파우더는 무독하며, 떫은맛이 없어 복용이 편리하고 순환계질환 환자에게 건강보조식품으로 이용이 가능하다는 특장점이 있다.As described above, the sea pine leaf extract powder of the present invention is non-toxic and has no astringent taste, which is convenient to take and can be used as a health supplement food for patients with circulatory diseases.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950001352A KR0184719B1 (en) | 1995-01-26 | 1995-01-26 | Pinus koraiensis sieb powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019950001352A KR0184719B1 (en) | 1995-01-26 | 1995-01-26 | Pinus koraiensis sieb powder |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960028913A KR960028913A (en) | 1996-08-17 |
KR0184719B1 true KR0184719B1 (en) | 1999-03-20 |
Family
ID=19407266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950001352A KR0184719B1 (en) | 1995-01-26 | 1995-01-26 | Pinus koraiensis sieb powder |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR0184719B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008035925A1 (en) * | 2006-09-22 | 2008-03-27 | Sang Kyum Kim | A feed composition comprising a leaf extract of pinus koraiensis showing antioxidative activity |
-
1995
- 1995-01-26 KR KR1019950001352A patent/KR0184719B1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008035925A1 (en) * | 2006-09-22 | 2008-03-27 | Sang Kyum Kim | A feed composition comprising a leaf extract of pinus koraiensis showing antioxidative activity |
Also Published As
Publication number | Publication date |
---|---|
KR960028913A (en) | 1996-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1300084B1 (en) | Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves | |
KR101834745B1 (en) | A manufacturing method of functional powder comprising abundant rutin ingredient | |
JP2015127339A (en) | Composition for anti-saccharification | |
JP5686328B2 (en) | Anti-glycation composition | |
AU710108B2 (en) | Medicinal composition for diabetes | |
KR100581216B1 (en) | Blended tea effective to eliminate nocotine with excellent preference | |
KR101082938B1 (en) | Vitamin agent composition comprising enrichmented water-soluble vitamins and method for preparing thereof | |
KR0184719B1 (en) | Pinus koraiensis sieb powder | |
JPH07223940A (en) | Active oxygen eliminating agent and composition containing the same | |
JPH05246866A (en) | Agent for stimulating cerebral metabolism and for improving cerebral function | |
KR100500521B1 (en) | Food composition having preventive effect of alcohol induced fatty liver and solving hang over problems and manufacturing method thereof | |
KR102538751B1 (en) | Pharmaceutical composition and food composition for treating erectile dysfunction | |
JPH04300836A (en) | Hepatic dysfunction preventive agent and functional food having preventive action on hepatic dysfunction | |
JP2015025008A (en) | Anti-glycation composition | |
JPH0840923A (en) | Nutrient-supplying agent | |
JP6607418B2 (en) | Anti-glycation composition | |
JP6260804B2 (en) | Anti-glycation composition | |
KR0179088B1 (en) | Composition containing rhodiola sachalinesis extract for prophylaxis and treatment of diabetes mellitus | |
JP2535674B2 (en) | Hypoglycemic agent | |
KR101490030B1 (en) | Cigarette filter FOR ANTI-TUSSIVE ACTIVITY OR DISCHARGE OF PHLEGM ACTIVITY COMPRISING EXTRACTS OF DENDROPANAX MORBIFERA | |
US20240307478A1 (en) | Phosphodiesterase 5 inhibitor | |
JP6447848B2 (en) | Anti-glycation composition | |
KR0179087B1 (en) | Composition containing rhodiola sachalinesis extract for lowering blood alcohol concentration | |
JP4712927B2 (en) | Chronic hepatitis inhibitor | |
JP4454069B2 (en) | Chronic hepatitis inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20031223 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |